Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Development of a Novel Series of Anticancer and Antidiabetic: Spirothiazolidines Analogs.

Flefel EM, El-Sofany WI, Al-Harbi RAK, El-Shahat M.

Molecules. 2019 Jul 9;24(13). pii: E2511. doi: 10.3390/molecules24132511.

2.

Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridineā»Pyrazole Hybrid Derivatives.

Flefel EM, El-Sofany WI, El-Shahat M, Naqvi A, Assirey E.

Molecules. 2018 Oct 6;23(10). pii: E2548. doi: 10.3390/molecules23102548.

3.

Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation.

Flefel EM, Tantawy WA, El-Sofany WI, El-Shahat M, El-Sayed AA, Abd-Elshafy DN.

Molecules. 2017 Jan 17;22(1). pii: E148. doi: 10.3390/molecules22010148.

4.

Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis.

Zaghloul H, El-Shahat M.

World J Hepatol. 2014 Dec 27;6(12):916-22. doi: 10.4254/wjh.v6.i12.916. Review.

5.

Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative.

Shamroukh AH, El-Shahat M, Drabowicz J, Ali MM, Rashad AE, Ali HS.

Eur J Med Chem. 2013 Nov;69:521-6. doi: 10.1016/j.ejmech.2013.09.005. Epub 2013 Sep 20.

PMID:
24095746
6.

New pyrimidinone and fused pyrimidinone derivatives as potential anticancer chemotherapeutics.

Rashad AE, Shamroukh AH, Yousif NM, Salama MA, Ali HS, Ali MM, Mahmoud AE, El-Shahat M.

Arch Pharm (Weinheim). 2012 Sep;345(9):729-38. doi: 10.1002/ardp.201200119. Epub 2012 Jun 6.

PMID:
22674829

Supplemental Content

Loading ...
Support Center